Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin C Taylor

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Nature|February 28, 2003
Mechanism of genetic exchange in American trypanosomesMichael W Gaunt, Matthew Yeo, Iain A Frame, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2018
Shaving Is an Epiphenomenon of Type I and II Anti-CD20-Mediated Phagocytosis, whereas Antigenic Modulation Limits Type I Monoclonal Antibody EfficacyLekh N Dahal, Chie-Yin Huang, Richard J Stopforth, et al.
European Journal of Medicinal Chemistry|October 20, 2015
Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activityOrnella Di Pietro, Esther Vicente-García, Martin C Taylor, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environmentsJulia Moreno-Vicente, Jane E Willoughby, Martin C Taylor, et al.
Nature Communications|March 14, 2020
A receptor for the complement regulator factor H increases transmission of trypanosomes to tsetse fliesOlivia J S Macleod, Jean-Mathieu Bart, Paula MacGregor, et al.
Plos Neglected Tropical Diseases|May 24, 2019
A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasisPaula MacGregor, Andrea L Gonzalez-Munoz, Fatoumatta Jobe, et al.
Nature Communications|August 29, 2022
Invariant surface glycoprotein 65 of Trypanosoma brucei is a complement C3 receptorOlivia J S Macleod, Alexander D Cook, Helena Webb, et al.
Cancer Immunology Research|September 26, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for ImmunotherapyKirstie L S Cleary, Monika Semmrich, Linda Martensson, et al.
Immunotherapy Advances|September 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axisLara V Graham, Ludmila Horehajova, Marco V Haselager, et al.
Frontiers in Pharmacology|May 23, 2022
Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and CancerYabalu Z Abacha, Arnold Donkor Forkuo, Stephen Y Gbedema, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Nature|February 28, 2003
Mechanism of genetic exchange in American trypanosomesMichael W Gaunt, Matthew Yeo, Iain A Frame, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2018
Shaving Is an Epiphenomenon of Type I and II Anti-CD20-Mediated Phagocytosis, whereas Antigenic Modulation Limits Type I Monoclonal Antibody EfficacyLekh N Dahal, Chie-Yin Huang, Richard J Stopforth, et al.
European Journal of Medicinal Chemistry|October 20, 2015
Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activityOrnella Di Pietro, Esther Vicente-García, Martin C Taylor, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environmentsJulia Moreno-Vicente, Jane E Willoughby, Martin C Taylor, et al.
Nature Communications|March 14, 2020
A receptor for the complement regulator factor H increases transmission of trypanosomes to tsetse fliesOlivia J S Macleod, Jean-Mathieu Bart, Paula MacGregor, et al.
Plos Neglected Tropical Diseases|May 24, 2019
A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasisPaula MacGregor, Andrea L Gonzalez-Munoz, Fatoumatta Jobe, et al.
Nature Communications|August 29, 2022
Invariant surface glycoprotein 65 of Trypanosoma brucei is a complement C3 receptorOlivia J S Macleod, Alexander D Cook, Helena Webb, et al.
Cancer Immunology Research|September 26, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for ImmunotherapyKirstie L S Cleary, Monika Semmrich, Linda Martensson, et al.
Immunotherapy Advances|September 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axisLara V Graham, Ludmila Horehajova, Marco V Haselager, et al.
Frontiers in Pharmacology|May 23, 2022
Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and CancerYabalu Z Abacha, Arnold Donkor Forkuo, Stephen Y Gbedema, et al.
Pageof 10